(Press-News.org) Nirupama Yechoor, MD, MSC, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in JAMA Network Open, “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scale.”
Q: How would you summarize your study for a lay audience?
As doctors who care for stroke survivors, we recognize that recovery is a long journey shaped by physical, emotional, mental and social challenges that extend beyond the hospital walls. We also recognize that many changes are needed to help all stroke survivors achieve their best recovery, which means optimizing both their health and their wellbeing. The first step to improving stroke recovery is understanding the lived experiences of stroke survivors and their care partners.
We conducted one of the largest qualitative studies with stroke survivors and care partners within the United States to better understand what wellbeing means in recovery. Through the lived experiences that participants shared with us, we identified key factors that shape physical and emotional wellbeing after stroke.
While medical care usually focuses on building physical strength and improving movement, stroke survivors struggle with additional emotional challenges such as facing stigma, living with uncertainty, and losing a part of their identity. Our study highlights the importance of integrating stroke survivors’ lived experiences in stroke research and provides a foundation for evaluating the nonclinical determinants that shape health, wellbeing and recovery.
Q: What was the main goal of your study?
Our goal was to understand the factors that shape physical and emotional wellbeing after stroke — as described by stroke survivors — and to assess whether the questionnaires that we commonly use in research or at the doctor’s office effectively capture all of these elements.
Q: What methods or approach did you use?
We applied qualitative research methods and studied the experiences of 41 stroke survivors and caregivers across the U.S. from October 2023 until December 2024.
We met stroke survivors and caregivers in small groups and asked them about their experiences related to physical and emotional wellbeing during recovery. We also compared stroke survivors’ experiences with questions included in the Stroke Specific Quality of Life or the SSQoL survey, which is commonly used by doctors and researchers. By comparing the two methodologies, we identified factors related to physical and emotional wellbeing that are well-represented in traditional medical care, and those areas that may be overlooked.
Q: What did you find?
We found that stroke recovery is shaped by more than physical factors — stroke survivors shared that their emotional recovery is just as important. We found five key factors of reduced physical functioning and social participation: the loss of independence, the fear of uncertainty, reduced community participation, feelings of shame and decreased physical mobility.
On comparing these factors to the SSQoL, we found that the SSQoL adequately captured some of these factors, but only partially captured other important factors like shame and uncertainty. Our study highlights a potential care gap in how stroke clinicians can address recovery for stroke survivors.
Q: What are the implications?
The implications of these findings are twofold. First, we have partnered with stroke survivors to identify their priorities that clinicians should address during follow-up care. Second, we have identified gaps in measuring these priorities, highlighting the need for alternative care models that address recovery in a more comprehensive way.
Q: What are the next steps?
The next steps are to use these findings to develop interventions that address more than physical recovery in stroke care, and are developed with patient and care partner input. We believe a key component that has been missing from stroke research is understanding the lived experiences of stroke survivors.
We would like to thank all of the stroke survivors and care partners who collaborated with our group for this research study. Their willingness to help other stroke survivors, their honesty in sharing their stories, and their resilience in recovery has been inspiring for our team to continue this important work.
Authorship: In addition to Nirupama Yechoor, co-authors include Devanshi Choksi, Mary Craven, Taylor McVeigh, Akashleena Mallick, Tanzeela Ranman, Christina Kourkoulis, Sofia Constantinescu, Rachel Kitagawa, Emilie Egger, Lindsay Rosenfeld, Rachel Forman, Guido J. Falcone, Jonathan Rosand, and Vanessa L. Merker.
Paper cited: Choksi, D., et al. “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scale” JAMA Network Open. DOI: 10.1001/jamanetworkopen.2025.3795
Funding: This work was supported by grants from the Bugher Collaborative Project (PI, Dr. Falcone; No. 23BFHSCP1178409; Dr. Rosand; No. 23BFHSCP1176239).
Disclosures: D. Choksi is supported by the Lavine Brain Health Innovation Fund. G.J. Falcone is supported by the AHA (817874, 24GWTGSIC1341098, 23BFHSCP1178409) and the NIH (P30AG021342, U01NS106513, RF1NS139183). J. Rosand has a leadership or fiduciary role at Columbia University, Lancet Neurology, and European Stroke Journal.
END
Research Spotlight: Mapping overlooked challenges in stroke recovery
Nirupama Yechoor, MD, MSC, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in JAMA Network Open, “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scal
2025-10-17
ELSE PRESS RELEASES FROM THIS DATE:
Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US
2025-10-17
About The Study: The findings of this study suggest that despite increasing screening overall, which led to reduced geographic variation in screening, local clusters of high and low screening persisted in the Northeast and Southwest U.S., respectively. Future studies could incorporate county-level health care access characteristics to explain why areas of low screening did not catch up to optimize cancer screening practices.
Corresponding Author: To contact the corresponding author, Timothy R. Rebbeck, PhD, email timothy_rebbeck@dfci.harvard.edu.
To access the ...
Cannabis laws and opioid use among commercially insured patients with cancer diagnoses
2025-10-17
About The Study: This study’s findings indicate cannabis may be a substitute for opioids in the management of cancer-related pain. However, further research directly observing cannabis use is needed to evaluate the efficacy of cannabis as a treatment for cancer-related pain.
Corresponding Author: To contact the corresponding author, Victoria Bethel, MSN, email vbethel@uga.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2025.3512)
Editor’s Note: Please see the article ...
Research Spotlight: Surprising gene mutation in brain’s immune cells linked to increased Alzheimer’s risk
2025-10-17
Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, “The Gain-of-Function TREM2-T96K Mutation Increases Risk for Alzheimer’s Disease by Impairing Microglial Function.”
Q: How would you summarize your study for a lay audience?
Our team wanted to understand how immune cells of the brain, called microglia, contribute to Alzheimer’s disease (AD) pathology. It’s known that subtle changes, or mutations, in genes expressed in microglia are associated with an increased ...
Missing molecule may explain Down syndrome
2025-10-17
Faulty brain circuits seen in Down syndrome may be caused by the lack of a particular molecule essential for the development and function of the nervous system, new research suggests. Restoring the molecule, called pleiotrophin, could improve brain function in Down syndrome and other neurological diseases – possibly even in adults, the researchers say.
The scientists conducted their work in lab mice, rather than in people, so the approach is far from being available as a treatment. But the researchers found that administering pleiotrophin improved brain function in adult ...
Donor diabetes and 1-year Descemet membrane endothelial keratoplasty success rate
2025-10-17
About The Study: The 1-year success rate in eyes undergoing Descemet membrane endothelial keratoplasty (DMEK) with successfully prepared tissue was very high regardless of donor diabetes status. These results, supported by the separately reported finding that endothelial cell loss and cornea morphometry after 1 year were not affected by donor diabetes status, provide strong support for having no restrictions on the use of tissue from donors with diabetes for DMEK.
Corresponding Author: To contact the corresponding author, Jonathan H. Lass, MD, email deks@case.edu.
To access the embargoed study: Visit our For The Media website at this link ...
Endothelial cell loss 1 year after successful DMEK in the diabetes endothelial keratoplasty study
2025-10-17
About The Study: This randomized clinical trial found that endothelial cell loss and morphometry 1 year after Descemet membrane endothelial keratoplasty (DMEK) were not affected by cornea donor diabetes status. With comparable 1-year graft success with tissue from donors with and without diabetes demonstrated in this trial, these findings support the use of corneas from donors with diabetes for endothelial keratoplasty procedures.
Corresponding Author: To contact the corresponding author, Jonathan ...
Overactive Runx1 gene triggers early disc degeneration linked to aging
2025-10-17
“Taken together, these findings reveal a novel role of Runx1 in maintaining disc health and regulating age-related degenerative processes.”
BUFFALO, NY — October 17, 2025 — A new research paper was published in Volume 17, Issue 9 of Aging-US on September 8, 2025, titled, “Runx1 overexpression induces early onset of intervertebral disc degeneration.”
In this study, led by first author Takanori Fukunaga from Emory University School of Medicine and corresponding author Hicham Drissi from Emory and the Atlanta VA Medical Center, researchers found that the Runx1 gene, when overactive in spinal disc cells, ...
NYU Langone Health chair of ophthalmology, Dr. Kathryn Colby, honored with Castroviejo Medal at AAO 2025
2025-10-17
ORLANDO, FLORIDA, OCTOBER 17, 2025—NYU Langone Health ophthalmology faculty present their latest research at this year’s annual meeting of the American Academy of Ophthalmology (AAO), where Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor and chair of the Department of Ophthalmology at NYU Grossman School of Medicine, will be awarded the prestigious Castroviejo Medal from the Cornea Society. This honor recognizes Dr. Colby’s groundbreaking contributions to the field of ophthalmology, particularly in the promotion, research, and understanding of the cornea.
Among the presentations at AAO in Orlando, October 17 ...
Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer
2025-10-17
BERLIN October 17, 2025 – Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed EGFR-mutated advanced non-small cell lung cancer (NSCLC) compared to osimertinib alone. The finding is based on an analysis of the complete data from the phase 3 global FLAURA2 study, co-led by researchers from Dana-Farber Cancer Institute and Gustave Roussy (Grand Paris, Villejuif, France). Median overall survival was 47.5 months in the osimertinib plus platinum–pemetrexed group versus 37.6 months ...
FAU’s Queen Conch Lab receives prestigious international award
2025-10-17
The Florida Atlantic University Harbor Branch Oceanographic Institute’s Queen Conch Lab, led by research professor Megan Davis, Ph.D., has been named the recipient of the 2025 Responsible Seafood Innovation Award in Aquaculture from the Global Seafood Alliance (GSA).
The award honors the Queen Conch Lab’s development of mobile lab hatcheries designed to help restore the threatened Caribbean queen conch. These self-contained, trailer-based hatcheries bring advanced aquaculture capabilities to coastal communities across the Caribbean, many of which lack traditional infrastructure. This innovation is not only helping to rebuild wild ...
LAST 30 PRESS RELEASES:
Exploring why adapting to the environment is more difficult as people age
Society for Laboratory Automation and Screening welcomes new scientific director: Madeline M. Farley, Ph.D.
Austrian cow shows first case of flexible, multi-purpose tool use in cattle
Human nasal passages defend against the common cold and help determine how sick we get
Research alert: Spreading drug costs over the year may ease financial burden for Medicare cancer patients
Hospital partnership improves follow up scans, decreases long term risk after aortic repair
Layered hydrogen silicane for safe, lightweight, and energy-efficient hydrogen carrier
Observing positronium beam as a quantum matter wave for the first time
IEEE study investigates the effects of pointing error on quantum key distribution systems
Analyzing submerged fault structures to predict future earthquakes in Türkiye
Quantum ‘alchemy’ made feasible with excitons
‘Revoice’ device gives stroke patients their voice back
USF-led study: AI helps reveal global surge in floating algae
New method predicts asthma attacks up to five years in advance
Researchers publish first ever structural engineering manual for bamboo
National poll: Less than half of parents say swearing is never OK for kids
Decades of suffering: Long-term mental health outcomes of Kurdish chemical gas attacks
Interactional dynamics of self-assessment and advice in peer reflection on microteaching
When aging affects the young: Revealing the weight of caregiving on teenagers
Can Canada’s health systems handle increased demand during FIFA World Cup?
Autistic and non-autistic faces may “speak a different language” when expressing emotion
No clear evidence that cannabis-based medicines relieve chronic nerve pain
Pioneering second-order nonlinear vibrational nanoscopy for interfacial molecular systems beyond the diffraction limit
Bottleneck in hydrogen distribution jeopardises billions in clean energy
Lung cancer death rates among women in Europe are finally levelling off
Scientists trace microplastics in fertilizer from fields to the beach
The Lancet Obstetrics, Gynecology, & Women’s Health: Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities, confirms new gold-standard evidence review
Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities
Harm reduction vending machines in New York State expand access to overdose treatment and drug test strips, UB studies confirm
University of Phoenix releases white paper on Credit for Prior Learning as a catalyst for internal mobility and retention
[Press-News.org] Research Spotlight: Mapping overlooked challenges in stroke recoveryNirupama Yechoor, MD, MSC, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in JAMA Network Open, “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scal